Skip to main content

Notice for methotrexate (Link Medical Products Pty Ltd T/A Link Pharmaceuticals)

Active ingredients
methotrexate
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Oral liquid, solution
Indication
For the treatment of Acute Lymphoblastic Leukaemia (ALL)

Help us improve the Therapeutic Goods Administration site